Cefpodoxime Supplier-Buyer Network — Trade Flow Analysis

Name: Cefpodoxime Supplier-Buyer Trade Network Dataset — 178+ Indian Exporters, 23+ Importers, 78+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cefpodoxime supplier network, Cefpodoxime buyers, pharmaceutical export India, Cefpodoxime trade data

TransData Nexus

Cefpodoxime

India Pharmaceutical Trade Intelligence

$79.5M178 Suppliers78 CountriesHS 30042019

ExportsIndia → UNITED STATES69.6%India → FRANCE5.8%

ImportsUNITED STATES → India$865 FRANCE → India$34

#1 Supplier: ALKEM LABORATORIES

Who Supplies Cefpodoxime? Top Manufacturers & Buyers 2026 — ALKEM LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1ALKEM LABORATORIES LIMITED

ALKEM LABORATORIES LIMITED is the first-largest Cefpodoxime exporter from India, with a market share of 34.9% and a total export value of $27.8M across 29 shipments. Their average shipment value of $957.9K is above the market average of $45.9K, suggesting premium or bulk contract pricing.

ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. AMICI PHARMACEUTICALS is the dominant customer, accounting for 96.6% of this supplier's tracked business. Top customers include:

• AMICI PHARMACEUTICALS — $26.8M across 28 shipments (96.6% of this supplier's total exports)

• ASCEND LABORATORIES, — $485.5K across 1 shipments (1.7% of this supplier's total exports)

• PLANET PHARMA — $325.2K across 0 shipments (1.2% of this supplier's total exports)

• GOLDEN STATE MEDICAL — $85.5K across 0 shipments (0.3% of this supplier's total exports)

• ASCEND LABORATORIES — $38.9K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $957.9K is 1989% above the market average of $45.9K, consistent with large-order contracts or value-added formulations.

2AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the second-largest Cefpodoxime exporter from India, with a market share of 12.8% and a total export value of $10.2M across 219 shipments. Their average shipment value of $46.5K is above the market average of $45.9K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CRONUS PHARMA LLC — $3.3M across 72 shipments (32.8% of this supplier's total exports)

• CRONUS PHARMA LLC — $2.4M across 53 shipments (24.0% of this supplier's total exports)

• AUROLOGISTICS LLC — $1.9M across 41 shipments (18.8% of this supplier's total exports)

• AUROBINDO PHARMA USA, INC, — $1.4M across 29 shipments (13.4% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.1M across 24 shipments (11.0% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $46.5K is 1% above the market average of $45.9K, consistent with large-order contracts or value-added formulations.

3AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED is the third-largest Cefpodoxime exporter from India, with a market share of 8.3% and a total export value of $6.6M across 89 shipments. Their average shipment value of $74.5K is above the market average of $45.9K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MCKESSON THIRD PARTY LOGISTICS — $2.5M across 34 shipments (38.0% of this supplier's total exports)

• AUROBINDO PHARMA USA, INC, — $1.5M across 20 shipments (22.9% of this supplier's total exports)

• CRONUS PHARMA LLC — $1.2M across 15 shipments (17.4% of this supplier's total exports)

• AUROBINDO PHARMA USA, INC, — $822.1K across 11 shipments (12.4% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $617.8K across 8 shipments (9.3% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $74.5K is 63% above the market average of $45.9K, consistent with large-order contracts or value-added formulations.

4LUPIN LIMITED

LUPIN LIMITED is the fourth-largest Cefpodoxime exporter from India, with a market share of 6.8% and a total export value of $5.4M across 297 shipments. Their average shipment value of $18.3K is below the market average of $45.9K, reflecting a high-volume, competitive pricing strategy.

LUPIN LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ALKALOID AD SKOPJE — $2.2M across 120 shipments (40.3% of this supplier's total exports)

• CSPM — $1.0M across 57 shipments (19.3% of this supplier's total exports)

• CENTRE SPECIALITIES PHARMACEUTIQUES — $842.8K across 46 shipments (15.5% of this supplier's total exports)

• MERCKLE GMBH — $785.6K across 43 shipments (14.4% of this supplier's total exports)

• MERCKLE GMBH NGER — $572.8K across 31 shipments (10.5% of this supplier's total exports)

Key Insight: LUPIN LIMITED operates with high shipment frequency (297 shipments) at a per-shipment value of $18.3K, indicating a broad distribution network with many smaller, regular orders.

5MEDINOK HEALTHCARE PRIVATE LIMITED

MEDINOK HEALTHCARE PRIVATE LIMITED is the fifth-largest Cefpodoxime exporter from India, with a market share of 1.6% and a total export value of $1.3M across 10 shipments. Their average shipment value of $130.3K is above the market average of $45.9K, suggesting premium or bulk contract pricing.

MEDINOK HEALTHCARE PRIVATE LIMITED serves 3 named buyers in our database. AMDWYR FOR IMPORT AND EXPORT is the dominant customer, accounting for 65.8% of this supplier's tracked business. Top customers include:

• AMDWYR FOR IMPORT AND EXPORT — $857.9K across 7 shipments (65.8% of this supplier's total exports)

• MODERM INTERNATIONAL — $443.5K across 3 shipments (34.0% of this supplier's total exports)

• AWAI PHARMACEUTICALS — $1.5K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: MEDINOK HEALTHCARE PRIVATE LIMITED's per-shipment value of $130.3K is 184% above the market average of $45.9K, consistent with large-order contracts or value-added formulations.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Cefpodoxime exporter from India, with a market share of 1.6% and a total export value of $1.3M across 32 shipments. Their average shipment value of $39.6K is below the market average of $45.9K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 51.0% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $647.0K across 16 shipments (51.0% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $251.9K across 6 shipments (19.9% of this supplier's total exports)

• M/S. PLANET PHARMA — $136.0K across 3 shipments (10.7% of this supplier's total exports)

• M/S. GIGI MEDICAL ST — $118.4K across 3 shipments (9.3% of this supplier's total exports)

• RANBAXY SOUTH AFRICA — $115.0K across 3 shipments (9.1% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (32 shipments) at a per-shipment value of $39.6K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Cefpodoxime imports from India, with a total trade value of $55.3M across 185 shipments — representing a 69.6% share of all Cefpodoxime exports. The average shipment value of $299.0K is above the global average of $45.9K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.

Named Cefpodoxime importers in United States: AMICI PHARMACEUTICALS is the largest buyer, accounting for 48.7% ($27.0M) of this market's total imports.

• AMICI PHARMACEUTICALS — $27.0M (48.7% of United States's total)

• CRONUS PHARMA LLC — $5.5M (10.0% of United States's total)

• CRONUS PHARMA LLC, — $4.0M (7.3% of United States's total)

Key Insight: United States's per-shipment average of $299.0K (552% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Cefpodoxime imports from India.

Primary Market

Secondary Market

2France

France ranks as the second-largest destination for Cefpodoxime imports from India, with a total trade value of $4.6M across 55 shipments — representing a 5.8% share of all Cefpodoxime exports. The average shipment value of $84.0K is above the global average of $45.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Cefpodoxime importers in France: CENTRE SPECIALITIES PHARMACEUTIQUES is the largest buyer, accounting for 26.0% ($1.2M) of this market's total imports.

• CENTRE SPECIALITIES PHARMACEUTIQUES — $1.2M (26.0% of France's total)

• CSPM — $1.0M (22.7% of France's total)

Key Insight: France's per-shipment average of $84.0K (83% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Cefpodoxime imports from India.

Primary Market

Secondary Market

3Sudan

Sudan ranks as the third-largest destination for Cefpodoxime imports from India, with a total trade value of $3.1M across 6 shipments — representing a 3.8% share of all Cefpodoxime exports. The average shipment value of $509.2K is above the global average of $45.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cefpodoxime importers in Sudan: AMDWYR FOR IMPORT AND EXPORT is the largest buyer, accounting for 28.2% ($863.0K) of this market's total imports.

• AMDWYR FOR IMPORT AND EXPORT — $863.0K (28.2% of Sudan's total)

Key Insight: Sudan's per-shipment average of $509.2K (1010% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sudan is a key market for Cefpodoxime imports from India.

Primary Market

Secondary Market

4Vietnam

Vietnam ranks as the fourth-largest destination for Cefpodoxime imports from India, with a total trade value of $2.6M across 0 shipments — representing a 3.2% share of all Cefpodoxime exports. The average shipment value of $2.6M is above the global average of $45.9K, indicating high-value procurement contracts or branded formulations.

Key Insight: Vietnam's per-shipment average of $2.6M (5477% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Cefpodoxime imports from India.

Primary Market

Secondary Market

5Macedonia,the Former Yugoslav Republic Of

Macedonia,the Former Yugoslav Republic Of ranks as the fifth-largest destination for Cefpodoxime imports from India, with a total trade value of $2.2M across 0 shipments — representing a 2.8% share of all Cefpodoxime exports. The average shipment value of $2.2M is above the global average of $45.9K, indicating high-value procurement contracts or branded formulations.

Key Insight: Macedonia,the Former Yugoslav Republic Of's per-shipment average of $2.2M (4685% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Macedonia,the Former Yugoslav Republic Of is a key market for Cefpodoxime imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cefpodoxime.
2.Flow Mapping: 178 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,734 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 78 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,734 Verified Shipments

178 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cefpodoxime

Cefpodoxime

Who Supplies Cefpodoxime? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Cefpodoxime — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cefpodoxime? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cefpodoxime Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ALKEM LABORATORIES LIMITED

2AUROBINDO PHARMA LTD

3AUROBINDO PHARMA LIMITED

4LUPIN LIMITED

5MEDINOK HEALTHCARE PRIVATE LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Cefpodoxime Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cefpodoxime Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2France

3Sudan

4Vietnam

5Macedonia,the Former Yugoslav Republic Of

People Also Ask — Cefpodoxime Supplier & Trade Network

Cefpodoxime Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology